| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $24.9M | +43.2% |
| R&D Expense | $6.0M | +26.3% |
| SG&A Expense | $16.1M | +35.2% |
| Operating Income | -$10.8M | -0.6% |
| Interest Expense | $749K | +217.4% |
| Pre-tax Income | -$11.3M | -66.1% |
| Income Tax | $71K | -34.9% |
| Net Income | -$11.4M | -73.9% |
| EPS (Basic) | -$0.23 | -53.3% |
| EPS (Diluted) | -$0.23 | -53.3% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | -33.3% |
| Accounts Receivable | $7.7M | +101.9% |
| Current Assets | $16.0M | +5.7% |
| Total Assets | $61.5M | -0.5% |
| Current Liabilities | $16.8M | +24.3% |
| Long-term Debt | $9.7M | -1.9% |
| Total Liabilities | $26.0M | -6.3% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $10K | -75.6% |
| Investing Cash Flow | -$1.9M | +85.3% |
| Financing Cash Flow | $5.8M | -76.0% |
| Stockholders' Equity |
| $35.5M |
| +4.3% |